About PharmaScience
PharmaScience is a company based in Montreal (Canada) founded in 1983. PharmaScience has completed 1 acquisition, including Aegera Therapeutics.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pharmascience Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$1.5 M (USD), Debt – Conventional
Oct 18, 2006
-
Investors
Dynex Capital
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of PharmaScience
Unlock access to complete
Unlock access to complete
Software Development Team
44 people
Leadership Team
20 people
Sales and Marketing
17 people
Finance and Accounting
15 people
Product Management Team
10 people
Legal and Compliance
5 people
Head Team
4 people
Senior Team
4 people
Unlock access to complete
Funding Insights of PharmaScience
Investors in PharmaScience
PharmaScience has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Dynex Capital and MMV Financial.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech & Life-Sciences focused Growth stage Venture Debt Firm investing in North America
|
Locked | Locked | Locked | |
|
REIT that invests in residential and commercial mortgage loans
|
Locked | Locked | Locked |
Investor details for PharmaScience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PharmaScience
PharmaScience has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Aegera Therapeutics.
Investment portfolio details for PharmaScience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule therapeutics for cancer and immune diseases are developed.
|
Locked | Locked | 2000 | Locked |
Complete acquisition details for PharmaScience
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PharmaScience
Detailed financials for PharmaScience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmascience Comparisons
Peer comparison for PharmaScience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PharmaScience
Detailed competitors of PharmaScience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmascience
Complete news archive for PharmaScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PharmaScience
PharmaScience was founded in 1983 and raised its 1st funding round 22 years after it was founded.
PharmaScience is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
PharmaScience was established in 1983 in Montreal, Canada, within the pharmaceutical sector. Generic, branded, and over-the-counter medications are produced across nearly 300 molecules in facilities compliant with regulatory standards. Domestic and international markets are served, while support resources and patient care programs are provided to healthcare professionals. A dedicated division handles specialty medications, and substantial resources are allocated to research and development efforts.
PharmaScience has made 1 acquisition, including Aegera Therapeutics.
PharmaScience has 2 investors. Key investors include Dynex Capital, and MMV Financial.